Calcipotriene (Page 2 of 2)

Geriatric Use

Of the total number of patients in clinical studies of calcipotriene cream, approximately 15% were 65 or older, while approximately 3% were 75 and over. There were no significant differences in adverse events for subjects over 65 years compared to those under 65 years of age. However, the greater sensitivity of older individuals cannot be ruled out.

ADVERSE REACTIONS

Clinical Trials Experience

In controlled clinical trials, the most frequent adverse experiences reported for calcipotriene cream, 0.005% were cases of skin irritation, which occurred in approximately 10 to 15% of patients. Rash, pruritus, dermatitis and worsening of psoriasis were reported in 1 to 10% of patients.

Postmarketing Experience

Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

The following adverse reactions associated with the use of calcipotriene cream have been identified post-approval: contact dermatitis, including allergic contact dermatitis.

OVERDOSAGE

Topically applied calcipotriene can be absorbed in sufficient amounts to produce systemic effects. Elevated serum calcium has been observed with excessive use of topical calcipotriene. If elevation in serum calcium should occur, discontinue treatment until normal calcium levels are restored (see PRECAUTIONS).

DOSAGE AND ADMINISTRATION

Apply a thin layer of calcipotriene cream to the affected skin twice daily and rub in gently and completely. The safety and efficacy of calcipotriene cream have been demonstrated in patients treated for eight weeks.

HOW SUPPLIED

Calcipotriene cream, 0.005% is available in:

NDC 51407-605-60 60 gram tube (1 tube per carton)

NDC 51407-605-12 120 gram tube (1 tube per carton)

STORAGE

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Do not freeze.

Manufactured by:

Glenmark Pharmaceuticals Limited

Colvale-Bardez, Goa 403513, India

Manufactured for:

glen-logo

Glenmark Pharmaceuticals Inc., USA

Mahwah, NJ 07430

Questions? 1 (888) 721-7115
www.glenmarkpharma-us.com

To report SUSPECTED ADVERSE REACTIONS, contact Glenmark Pharmaceuticals Inc., USA at 1 (888) 721-7115 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

March 2021

Marketed by:

GSMS, Incorporated

Camarillo, CA 93012 USA

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL-60 gm Carton

NDC 51407-605-12

Calcipotriene Cream, 0.005%

120 gm Carton label

//medlibrary.org/lib/images-rx/calcipotriene-10/51407-605-12cb-300x205.jpg
(click image for full-size original)
CALCIPOTRIENE
calcipotriene cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51407-605
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CALCIPOTRIENE (CALCIPOTRIENE) CALCIPOTRIENE 50 ug in 1 g
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL
CETOSTEARYL ALCOHOL
CETETH-20
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
GLYCERIN
MEDIUM-CHAIN TRIGLYCERIDES
MINERAL OIL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
WATER
PETROLATUM
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51407-605-60 1 TUBE in 1 CARTON contains a TUBE
1 60 g in 1 TUBE This package is contained within the CARTON (51407-605-60)
2 NDC:51407-605-12 1 TUBE in 1 CARTON contains a TUBE
2 120 g in 1 TUBE This package is contained within the CARTON (51407-605-12)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA205772 06/09/2015
Labeler — Golden State Medical Supply, Inc. (603184490)
Establishment
Name Address ID/FEI Operations
Glenmark Pharmaceuticals Limited 677318665 analysis (51407-605), manufacture (51407-605)

Revised: 12/2021 Golden State Medical Supply, Inc.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.